Guidant Catches Boston Scientific’s “Hail Mary” Offer; J&J Weighs Options
This article was originally published in The Gray Sheet
Executive Summary
Guidant's board of directors determined Jan. 17 that Boston Scientific's latest acquisition offer of $80 per share, or $27.2 bil., is superior to its previous agreement with Johnson & Johnson for $71 per share